NorthSea Therapeutics
Phase 3NorthSea Therapeutics B.V. is a Dutch biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic, cholestatic and fibrotic diseases.
Founded
2015
Focus
Small Molecules
About
NorthSea Therapeutics B.V. is a Dutch biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic, cholestatic and fibrotic diseases.
Funding History
2Total raised: $110M
Series C$50MForbionMar 15, 2023
Series B$60MForbionSep 15, 2021
Company Info
TypePrivate
Founded2015
LocationAmsterdam, Netherlands
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile